Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.345 USD | -4.15% | +12.63% | -20.55% |
May. 02 | CUREVAC : A missed opportunity | |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.55% | 782M | |
+41.17% | 50.93B | |
-0.33% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.95% | 26.02B | |
-21.46% | 18.9B | |
+7.56% | 13.21B | |
+24.63% | 12.17B | |
+30.49% | 12.16B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- Transcript : CureVac N.V., Q4 2023 Earnings Call, Apr 24, 2024